Skip to main content
. 2019 Feb 7;97(4):1722–1733. doi: 10.1093/jas/skz051

Table 5.

Effects of zearalenone (ZEA) on the relative expression of Keap1, Nrf2, GPX1, NQO1, HO1, and GCLM1 mRNA in the jejunum of postweaning gilts

Treatment2 P
Item1 Control ZEA0.5 ZEA1.0 ZEA1.5 SEM Treatment Linear Quadratic
Keap1 1.00a 0.58b 0.57b 0.59b 0.010 <0.001 <0.001 <0.001
Nrf2 1.00c 3.45b 4.08a 3.90a 0.080 <0.001 0.005 <0.001
GPX1 1.04c 1.45b 1.82a 1.53b 0.018 <0.001 0.002 0.002
NQO1 1.01d 1.49c 2.07b 3.16a 0.065 <0.001 <0.001 <0.001
HO1 1.00d 1.56c 2.09b 2.64a 0.061 <0.001 0.0802 <0.001
GCLM 1.00b 1.18b 2.29a 2.35a 0.057 <0.001 <0.001 <0.001

a–dMeans within a row with different superscripts differ (P < 0.05).

1 Nrf2 = nuclear factor erythroid 2–related factor 2; Keap1 = Kelch-like erythroid cell-derived protein with CNC homology (ECH)–associated protein 1; GPX1 = glutathione peroxidase 1; HO1 = hemeoxygenase 1; NQO1 = quinone oxidoreductase 1; GCLM = modifier subunit of glutamate-cysteine ligase.

2Control, ZEA0.5, ZEA1.0, and ZEA1.5 represent the basal diet with an additions of 0, 0.5, 1.0, and 1.5 mg/kg ZEA, respectively, with analyzed ZEA concentrations being 0, 0.52 ± 0.07, 1.04 ± 0.03, and 1.51 ± 0.13 mg/kg, respectively.

HHS Vulnerability Disclosure